• Carlos M Morel, Tara Acharya, Denis Broun, Ajit Dangi, Christopher Elias, N K Ganguly, Charles A Gardner, R K Gupta, Jane Haycock, Anthony D Heher, Peter J Hotez, Hannah E Kettler, Gerald T Keusch, Anatole F Krattiger, Fernando T Kreutz, Sanjaya Lall, Keun Lee, Richard Mahoney, Adolfo Martinez-Palomo, R A Mashelkar, Stephen A Matlin, Mandi Mzimba, Joachim Oehler, Robert G Ridley, Pramilla Senanayake, Peter Singer, and Mikyung Yun.
• Center for Technological Development in Health, Oswaldo Cruz Foundation (FIOCRUZ), Avenida Brasil 4365, Rio de Janeiro, RJ 21040-900, Brazil. morel@fiocruz.br
• Science. 2005 Jul 15; 309 (5733): 401-4.

AbstractGross inequities in disease burden between developed and developing countries are now the subject of intense global attention. Public and private donors have marshaled resources and created organizational structures to accelerate the development of new health products and to procure and distribute drugs and vaccines for the poor. Despite these encouraging efforts directed primarily from and funded by industrialized countries, sufficiency and sustainability remain enormous challenges because of the sheer magnitude of the problem. Here we highlight a complementary and increasingly important means to improve health equity: the growing ability of some developing countries to undertake health innovation.

16 keywords...

hide…